Billionaire Profile
Kiran Mazumdar-Shaw
Global Rank
#1195

Image: Prathyush Thomas | GFDL 1.2 | via Wikimedia Commons

Kiran Mazumdar-Shaw

CEO, Biopharmaceuticals
INDIA
Real-Time Net Worth
$3.54B
Estimated based on Biopharmaceuticals stock value as of March 6, 2026
+0.88% (24h)
Age
72
Source
Biopharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Kiran Mazumdar-Shaw is an Indian billionaire entrepreneur and the Executive Chairperson and founder of Biocon Limited and Biocon Biologics Limited, a biotechnology company based in Bangalore, India. Born on March 23, 1953, she is a pioneer in the Indian biotech industry, transforming Biocon from a small startup into a global biopharmaceutical leader. Her career has been marked by groundbreaking innovation, a commitment to affordable healthcare, and significant contributions to philanthropy. Her net worth is estimated at $3.3 billion, reflecting her success in the biopharmaceuticals sector. She is known for her leadership and vision, championing advancements in healthcare and advocating for compassion in capitalism. Her journey has made her one of the world's wealthiest self-made female entrepreneurs.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Kiran Mazumdar-Shaw was born on March 23, 1953, in Bangalore, Karnataka, to Gujarati parents. She graduated with a Bachelor of Science in Zoology from Bangalore University in 1973. She then pursued a Master's degree in brewing from the University of Ballarat, Melbourne, in 1975. Despite her initial aspirations to become a brewmaster, she faced gender discrimination upon her return to India, which led her to pursue biotechnology.

Rise to Success

In 1978, she founded Biocon India in a garage in Bangalore with a seed capital of Rs. 10,000. Facing skepticism and challenges as a young woman entrepreneur, she persevered and built Biocon into a leading biotechnology company. Biocon became the first Indian company to export enzymes to the U.S. and Europe. The company expanded into biopharmaceuticals, and in 2004, it became the first biotech company in India to issue an IPO.

Key Business Strategies

Mazumdar-Shaw's business strategy has focused on "affordable innovation." She developed cost-effective techniques and low-cost alternatives in biopharmaceuticals. Biocon's expansion into biosimilars has been a key driver of its success. She has also focused on research and development, establishing long-term supply contracts, and entering the U.S. market.

Philanthropy

Kiran Mazumdar-Shaw is committed to philanthropy, focusing on healthcare and education. She is a signatory of the Giving Pledge, committing to donate the majority of her wealth to philanthropic causes. Her initiatives include the Biocon Foundation and the Mazumdar-Shaw Medical Foundation, which focus on creating affordable healthcare models and addressing the financial burden of diseases like cancer. In 2023, she was recognized as the second most generous woman philanthropist in the EdelGive Hurun India Philanthropy List.

Career Milestones

1978

Founded Biocon India

Started Biocon India in Bangalore, which later became a leading biopharmaceutical company.

2000

World Economic Forum Technology Pioneer

Recognized as a Technology Pioneer by the World Economic Forum.

2004

Economic Times Businesswoman of the Year

Awarded the Economic Times Businesswoman of the Year.

2005

Padma Bhushan

Received the Padma Bhushan, one of India's highest civilian honors.

2020

EY World Entrepreneur of the Year

Named EY World Entrepreneur of the Year.

Philanthropy & Social Impact

Health & Education

Biocon Foundation

Undisclosed

Focuses on health and education initiatives.

Healthcare

Mazumdar-Shaw Medical Foundation

Undisclosed

Focuses on creating an affordable and sustainable cancer care model.

General Philanthropy

The Giving Pledge

Undisclosed

Committed to donate the majority of her wealth to philanthropic causes.

Business Philosophy & Leadership

Notable Quotes

"My legacy is going to be in affordable healthcare."

Leadership Principles

Dedication

Demonstrates unwavering commitment to her work.

Fighting Criticism

Ability to overcome criticism and persevere.

Risk-Taking

Courage to take calculated risks.

Affordable Innovation

Focuses on developing cost-effective techniques and low-cost alternatives.

Controversies & Challenges

2025

Bengaluru Infrastructure Remarks

Criticism of Bengaluru's infrastructure led to controversy and a public debate on her regional identity.